loader from loading.io
Dr RR Baliga's Philosophical Discourses: John Locke (England, 1632โ€“1704 CE) โ€“ Empiricism show art Dr RR Baliga's Philosophical Discourses: John Locke (England, 1632โ€“1704 CE) โ€“ Empiricism

Dr. Baliga's 'Podkasts for Curious Docs'

๐Ÿง  John Locke: Experience โ€ข Liberty โ€ข Toleration   Born a physician-philosopher, Locke championed empiricism โ€” the idea that knowledge begins with experience, not dogma. His tabula rasa shaped modern psychology, while his Two Treatises of Government defined rights, consent, and freedom that echo through modern democracies.   For clinicians, his legacy reminds us to: ๐Ÿ”น Trust observation and evidence over authority ๐Ÿ”น Respect patient autonomy and informed consent ๐Ÿ”น Foster pluralism and toleration in care   His vision of reason and tolerance remains medicineโ€™s...

info_outline
Evolocumab in Primary Prevention.โ€ ๐Ÿงฌ๐Ÿ›ก๏ธ๐ŸŽฏ LDL: Down 55%. CV Events: Down 25%. show art Evolocumab in Primary Prevention.โ€ ๐Ÿงฌ๐Ÿ›ก๏ธ๐ŸŽฏ LDL: Down 55%. CV Events: Down 25%.

Dr. Baliga's 'Podkasts for Curious Docs'

๐Ÿš€ VESALIUS-CV delivers powerful evidence: in high-risk patients without prior MI or stroke, evolocumab significantly reduced 3-point MACE by 25% and 4-point MACE by 19%, with LDL-C lowered to a median of 45 mg/dL.   ๐Ÿ’ก These results expand the horizon of prevention, showing that deep LDL reduction is both safe and effective in averting first cardiovascular events.   ๐Ÿซ€ Strong science. Clear signal. A new chapter in preventive cardiology.   #Cardiology #LDL #Prevention #VESALIUSCV

info_outline
Capillary Clues, Clinical Wins: Targeting Capillary Refill Time in Acute Septic Shock ๐Ÿ”๐Ÿฉธโœ… show art Capillary Clues, Clinical Wins: Targeting Capillary Refill Time in Acute Septic Shock ๐Ÿ”๐Ÿฉธโœ…

Dr. Baliga's 'Podkasts for Curious Docs'

๐Ÿซ€ Septic Shock, Refined at the Fingertips โฑ๏ธ   A powerful new JAMA (2025) trial brings us one step closer to truly personalized resuscitation. The ANDROMEDA-SHOCK-2 study shows that targeting capillary refill time (CRT) โ€” a simple bedside sign โ€” can shorten time on organ support vs usual care, without increasing mortality.   Key insight: Sometimes the most elegant solutions are low-tech, high-touch, and right at the bedside.   ๐Ÿง  Precision ๐Ÿคš Physiology ๐Ÿ’ก Pragmatism   #Sepsis #CriticalCare #PersonalizedMedicine #JAMA #Hemodynamics #ICU #Shock

info_outline
SOFA-2 ICU Unveiled ๐Ÿง โš™๏ธ๐Ÿ“Š 3 Million Patients, 9 Nations, One New Standard show art SOFA-2 ICU Unveiled ๐Ÿง โš™๏ธ๐Ÿ“Š 3 Million Patients, 9 Nations, One New Standard

Dr. Baliga's 'Podkasts for Curious Docs'

๐Ÿšจ SOFA-2 arrives โ€” a thoughtful evolution in critical care scoring ๐Ÿง ๐Ÿซ๐Ÿซ€   After nearly 30 years, the SOFA score has been modernized using data from >3.3 million ICU patients across 9 countries. The updated SOFA-2 incorporates contemporary respiratory and cardiovascular supports (HFNC, NIPPV, vasopressors, ECMO) and refines thresholds while preserving simplicity and bedside usability.   A meaningful step forward in describing organ dysfunction โ€” with room for future biologically grounded refinement.   ๐Ÿ“– Published in JAMA

info_outline
SOFA-2 Unveiled ๐Ÿง โš™๏ธ๐ŸŒ-๐Ÿ“Š๐Ÿฉบ๐Ÿšจ โ€” Critical Care Enters a New Era show art SOFA-2 Unveiled ๐Ÿง โš™๏ธ๐ŸŒ-๐Ÿ“Š๐Ÿฉบ๐Ÿšจ โ€” Critical Care Enters a New Era

Dr. Baliga's 'Podkasts for Curious Docs'

SOFA-2 is here โ€” a major advance in assessing organ dysfunction in critical illness ๐Ÿง ๐Ÿซโค๏ธ   Three decades after the original SOFA score, this updated framework reflects modern ICU practice โ€” integrating contemporary organ support (ventilation, vasopressors, RRT), delirium recognition, and global feasibility across resource settings ๐ŸŒ๐Ÿ“Š   Validated in 3.3M+ ICU patients across 9 countries โ€” a remarkable effort in global critical care science ๐Ÿฅ๐Ÿ“ˆ   A powerful step forward in our shared language of severity and recovery.   ๐Ÿ”— JAMA Network Open, 2025

info_outline
๐Ÿ’” Peripartum Cardiomyopathy: Detect Early โ€ข Treat Aggressively โ€ข Protect Mothers show art ๐Ÿ’” Peripartum Cardiomyopathy: Detect Early โ€ข Treat Aggressively โ€ข Protect Mothers

Dr. Baliga's 'Podkasts for Curious Docs'

๐Ÿ’” Peripartum Cardiomyopathy: When a Motherโ€™s Heart Fights for Two   Peripartum cardiomyopathy is a leading yet often missed cause of maternal morbidity and mortalityโ€”striking late in pregnancy or months postpartum. Early suspicion, timely echo, and guideline-directed therapy save lives. ๐Ÿฉบ   ๐Ÿง  Bromocriptine, careful anticoagulation, and multidisciplinary care are reshaping outcomes, but global disparities persist. ๐ŸŒ   Letโ€™s amplify awareness, strengthen systems, and protect mothers everywhere. ๐Ÿคโค๏ธ   #HeartFailure #MaternalHealth #Cardiology...

info_outline
Rethinking โ€œdefault arterial linesโ€ in the ICU ๐Ÿง ๐Ÿš‘ show art Rethinking โ€œdefault arterial linesโ€ in the ICU ๐Ÿง ๐Ÿš‘

Dr. Baliga's 'Podkasts for Curious Docs'

Rethinking โ€œdefault linesโ€ in the ICU ๐Ÿง ๐Ÿš‘   A landmark NEJM trial shows that in patients with shock, deferring arterial catheterization and using automated cuff monitoring was noninferior for 28-day mortality โ€” and reduced catheter-related complications.   A gentle reminder: not every sick patient needs a needle to be well cared for.   Precision isnโ€™t only invasive โ€” sometimes itโ€™s thoughtful, measured, humane. ๐ŸŒฟ๐Ÿ’ก   #CriticalCare #ICU #NEJM #Shock #Hemodynamics #PatientSafety

info_outline
Light Pollution, Circadian Disruption, Cardiac Vulnerability ๐ŸŒƒ๐Ÿ•ฐ๏ธ๐Ÿซ€ show art Light Pollution, Circadian Disruption, Cardiac Vulnerability ๐ŸŒƒ๐Ÿ•ฐ๏ธ๐Ÿซ€

Dr. Baliga's 'Podkasts for Curious Docs'

๐ŸŒ™ Bright Nights, Higher Heart Risk โค๏ธโ€๐Ÿฉน   New findings in JAMA Network Open highlight that greater exposure to artificial light at night is associated with significantly increased risks of coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, and stroke โ€” independent of sleep duration, lifestyle factors, and genetics.   ๐Ÿ’ก Clinical takeaway: Protecting circadian rhythms is cardiovascular prevention. Darker nights = healthier hearts.   ๐Ÿ›Œ Simple steps: blackout curtains, limit screens before bed, use warm/dim evening lighting....

info_outline
Rethinking Immune Aging: It Starts Sooner Than We Think ๐Ÿ’ก๐Ÿฉธ show art Rethinking Immune Aging: It Starts Sooner Than We Think ๐Ÿ’ก๐Ÿฉธ

Dr. Baliga's 'Podkasts for Curious Docs'

The immune clock starts earlier than we think โณ๐Ÿงฌ   A landmark Nature study shows that immune aging begins quietly in midlife โ€” decades before clinical frailty.   Using >16M single-cell profiles and longitudinal vaccine responses, researchers found: โ€ข Stable, early transcriptional drift in naรฏve & memory T cells โ€ข A subtle TH2 shift that may weaken antiviral antibody quality โ€ข Reduced IgG class-switching to repeat flu antigens (e.g., B/Phuket) โ€ข No acceleration from CMV infection despite compositional shifts   The message? Immune aging is gradual, not...

info_outline
Seven Years Later: TAVR Didnโ€™t Blink ๐Ÿ˜Ž๐Ÿซ€ show art Seven Years Later: TAVR Didnโ€™t Blink ๐Ÿ˜Ž๐Ÿซ€

Dr. Baliga's 'Podkasts for Curious Docs'

๐Ÿซ€ TAVR or SAVR? The 7-Year Truth   New 7-year results from the PARTNER-3 trial (NEJM) show that in low-risk patients with severe symptomatic aortic stenosis, TAVR holds pace with surgery โ€” delivering comparable survival, stroke rates, rehospitalization, valve durability, and quality-of-life outcomes.   ๐Ÿ”Ž Highlights โ€ข Composite events: 34.6% (TAVR) vs 37.2% (SAVR) โ€ข Mortality: 19.5% vs 16.8% โ€ข Valve failure: 6.9% vs 7.3% โ€ข Aortic gradients remain low in both groups   ๐Ÿ’ก Clinical rhythm: less AF with TAVR; more pacemakers and paravalvular leak.   This study...

info_outline
 
More Episodes

๐Ÿšจ Just read the latest Lancet 2025 Seminar on Large-Vessel Vasculitis โ€“ a must-read for anyone tracking ๐Ÿ” Giant Cell Arteritis, ๐Ÿ’ฅ Takayasu Arteritis, and ๐Ÿงฌ Isolated Aortitis. From ๐Ÿš‘ clinical phenotypes to ๐Ÿง  imaging advances and ๐ŸŽฏ targeted biologics like tocilizumab and JAK inhibitors, this article bridges inflammation with innovation.

๐Ÿ“ธ Vascular imaging, ๐Ÿ”ฌ immunopathology, and ๐Ÿงช new therapiesโ€”essential insights for rheumatology, cardiology & internal medicine teams.

๐Ÿ“– Read it, teach it, share it! #Vasculitis #GCA #TAK #Immunology #PrecisionMedicine #Lancet2025